Systematic Evaluation of Effectiveness and Safety of Zhengtian Pill for Migraine

CHEN Jie; LIANG Wei-xiong; QIN Shao-chen; HEI Shang-yan; LIU Qiong

doi:10.13422/j.cnki.syfjx.2015190194

您当前的位置：

首页 >

文章列表页 >

Systematic Evaluation of Effectiveness and Safety of Zhengtian Pill for Migraine

更新时间：2024-01-04

- Systematic Evaluation of Effectiveness and Safety of Zhengtian Pill for Migraine
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 21, Issue 19, Pages: 194-200(2015)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2015190194
  CLC： R277.7
- Published：2015
- 稿件说明：
移动端阅览
CHEN Jie, LIANG Wei-xiong, QIN Shao-chen, et al. Systematic Evaluation of Effectiveness and Safety of Zhengtian Pill for Migraine[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 194-200.
DOI：

CHEN Jie, LIANG Wei-xiong, QIN Shao-chen, et al. Systematic Evaluation of Effectiveness and Safety of Zhengtian Pill for Migraine[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 194-200. DOI： 10.13422/j.cnki.syfjx.2015190194.

摘要

目的:系统评价正天丸治疗偏头痛的有效性和安全性。方法:计算机检索国内外数据库(从创建到2014年12月)

查找正天丸与常规西药或安慰剂对照治疗偏头痛的随机对照试验(RCT)的文献。由2位评价员按纳入和排除标准独立筛选文献、提取资料和评价纳入研究的方法学质量后

采用RevMan 5.3.0进行Meta分析。结果:纳入15个RCT

共956例患者。Meta分析显示:①正天丸联合尼莫地平治疗的总有效率优于对照组[RR=1.44

95%CI(1.2

1.74)

P=0.000 1];②正天丸联合西比灵治疗在总有效率[RR=1.21

95%CI(1.08

1.35)

P=0.000 9]

偏头痛持续时间[MD=-0.84

95%CI(-12.03

-4.88)

P<0.000 01]方面优于对照组;③正天丸与阿司匹林对照的总有效率差异无统计学意义[RR=1.21

95%CI(0.99

1.49)

P=0.06];④正天丸与模拟剂对照

在总有效率[RR=2.5

95%CI(1.83

3.41)

P=0.000 01]

偏头痛持续时间[MD=-1.31

95%CI(-1.60

-1.02)

P<0.000 01]

发作次数[MD=-1.42

95%CI(-1.81

-1.03)

P=0.000 01]

发作天数[MD=-1.25

95%CI(-1.91

-0.60)

P<0.000 01]

发作程度[MD=-1.11

95%CI(-1.43

-0.79)

P<0.000 01]

改善伴随症状(恶心[MD=-1.11

95%CI(-1.27

-0.95)

P<0.000 01]

畏光[MD=-0.43

95%CI(-0.81

-0.28)

P<0.000 01]

流泪[MD=-0.54

95%CI(-0.7

-0.38)

P<0.000 01]}等方面

均优于对照组。但从已有证据尚无法判断正天丸与所报告不良事件的关系。结论:目前证据提示正天丸治疗偏头痛疗效确切

在改善偏头痛发作程度、减少发作时间、减轻部分伴随症状等方面优于安慰剂

治疗偏头痛总有效率与阿司匹林相当

正天丸联合西药(尼莫地平或西比灵)治疗的效果优于纯西药治疗。但由于纳入研究的文献质量较低

本结论的可靠性和外推性有待更多高质量的随机对照试验的验证。

Abstract

Objective: To systematically evaluate the effectiveness and safety of Zhengtian pill for migraine. Method: The randomized controlled trails(RCTs) of Zhengtian pill and conventional western medicine or placebo in treating migraine were searched in domestic and overseas databases through computer. Literature screening

information extracting and literature quality assessment were completed by 2 reviewers independently. And Revman 5.3.0 software was adopted for the meta analysis. Result: Totally 15 RCTs involving 956 patients were included. The results showed that when compared with the control group

Zhengtian pill combined with Nimodipine group was superior in the total effective rate[RR=1.44

95%CI(1.2

1.74)

P=0.000 1]

Zhengtian pill combined with Flunarizine group had a better effective rate[RR=1.21

95%CI(1.08

1.35)

P=0.000 9] and a shorter headache duration[MD=-0.84

95%CI(-12.03

-4.88)

P<0.000 01];when compared with the aspirin group

Zhentian pill group had no statistical difference in the total effective rate[RR=1.21

95%CI(0.99

1.49)

P=0.06];when compared with the placebo group

Zhentian pill had a better effective rate[RR=2.5

95%CI(1.83

3.41)

P=0.000 01]

shorter headache duration[MD=-1.31

95%CI(-1.60

-1.02)

P<0.000 01]

lower frequency of headache[MD=-1.42

95%CI(-1.81

-1.03)

P=0.000 01]

less episode days[MD=-1.25

95%CI(-1.91

-0.60)

P<0.000 01]

decreased headache degree[MD=-1.11

95%CI(-1.43

-0.79)

P<0.000 01] and better conditions for the accompanied symptoms such as nausea[MD=-1.11

95%CI(-1.27

-0.95)

P<0.000 01]

photophobia[MD=-0.43

95%CI(-0.81

-0.28)

P<0.000 01] and less tears[MD=-0.54

95%CI(-0.7

-0.38)

P<0.000 01]. But the existing evidences cannot verify the relations between Zhengtian pill and reported adverse events. Conclusion: The current evidences showed that Zhengtian pill is effective in treating migraine

with better effects than placebo in reducing headache degree and headache duration and relieving accompanied symptoms

and equal overall response rate with Aspirin in treating migraine. The combination of Zhengtian pill and Nimodipine or Flunarizine had a better efficacy than simple administration of western medicine. But more RCTs with higher qualities are required to confirm the reliability and extrapolation of our conclusion.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Comprehensive Clinical Evaluation of Duliang Soft Capsules in Treatment of Migraine with Wind-cold Blood Stasis Syndrome

Modified Sanpiantang Treats Nitroglycerin-induced Migraine in Rats via p38 MAPK/iNOS Signaling Pathway

Clinical Efficacy of Xiaoyaosan Combined with Paroxetine Tablets in Treatment of Migraine with Liver Depression and Blood Deficiency Syndrome and Depression Based on Transcranial Doppler

Mechanism of Mahuang Xixin Fuzitang Against Migraine Based on Network Pharmacology and Experimental Validation

Modified Sanpiantang in Treatment of Migraine： A Review

Related Author

ZHAO Xiaoxiao

ZHANG Xuming

XI Junyu

LU Zhenkai

LIU Fumei

WANG Lianxin

LI Yuanyuan

XIE Yanming

Related Institution

Graduate School， Tianjin University of Traditional Chinese Medicine

Institute of Basic Research in Clinical Medicine，China Academy of Chinese Medical Sciences

School of Pharmacy， Henan University of Chinese Medicine

Henan Provincial Hospital of Traditional Chinese Medicine/The Second Affiliated Hospital of Henan University of Chinese Medicine

Graduate School of Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰